» Articles » PMID: 27126040

Population-based Metagenomics Analysis Reveals Markers for Gut Microbiome Composition and Diversity

Abstract

Deep sequencing of the gut microbiomes of 1135 participants from a Dutch population-based cohort shows relations between the microbiome and 126 exogenous and intrinsic host factors, including 31 intrinsic factors, 12 diseases, 19 drug groups, 4 smoking categories, and 60 dietary factors. These factors collectively explain 18.7% of the variation seen in the interindividual distance of microbial composition. We could associate 110 factors to 125 species and observed that fecal chromogranin A (CgA), a protein secreted by enteroendocrine cells, was exclusively associated with 61 microbial species whose abundance collectively accounted for 53% of microbial composition. Low CgA concentrations were seen in individuals with a more diverse microbiome. These results are an important step toward a better understanding of environment-diet-microbe-host interactions.

Citing Articles

Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn's disease: a prospective trial.

Zou B, Liu S, Dong C, Shen H, Lv Y, He J J Transl Med. 2025; 23(1):288.

PMID: 40050917 PMC: 11887145. DOI: 10.1186/s12967-024-05832-1.


Gut-X axis.

Lin X, Yu Z, Liu Y, Li C, Hu H, Hu J Imeta. 2025; 4(1):e270.

PMID: 40027477 PMC: 11865426. DOI: 10.1002/imt2.270.


Population-level gut microbiome and its associations with environmental factors and metabolic disorders in Southwest China.

Qu Q, Dou Q, Xiang Z, Yu B, Chen L, Fan Z NPJ Biofilms Microbiomes. 2025; 11(1):24.

PMID: 39905038 PMC: 11794850. DOI: 10.1038/s41522-025-00661-6.


Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease.

Zhang Y, Mo C, Ai P, He X, Xiao Q, Yang X Gut Microbes. 2025; 17(1):2454937.

PMID: 39875349 PMC: 11776486. DOI: 10.1080/19490976.2025.2454937.


The Gut Microbiota-Related Antihyperglycemic Effect of Metformin.

Szymczak-Pajor I, Drzewoski J, Kozlowska M, Krekora J, Sliwinska A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861118 PMC: 11768994. DOI: 10.3390/ph18010055.


References
1.
Tibble J, Sigthorsson G, Foster R, Scott D, Fagerhol M, Roseth A . High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999; 45(3):362-6. PMC: 1727647. DOI: 10.1136/gut.45.3.362. View

2.
Poullis A, Foster R, Mendall M, Shreeve D, Wiener K . Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity. Eur J Gastroenterol Hepatol. 2003; 15(5):573-4; author reply 574. DOI: 10.1097/00042737-200305000-00021. View

3.
DeSantis T, Hugenholtz P, Larsen N, Rojas M, Brodie E, Keller K . Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006; 72(7):5069-72. PMC: 1489311. DOI: 10.1128/AEM.03006-05. View

4.
Lee T, Shimizu T, Iijima M, Obinata K, Yamashiro Y, Nagasawa S . Evaluation of psychosomatic stress in children by measuring salivary chromogranin A. Acta Paediatr. 2006; 95(8):935-9. DOI: 10.1080/08035250500538940. View

5.
Crenn P, Messing B, Cynober L . Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008; 27(3):328-39. DOI: 10.1016/j.clnu.2008.02.005. View